Open Government Portal
Found 10 records similar to Report on Hepatitis B and C in Canada: 2018
In 2019, there were 4,912 hepatitis B cases reported for a rate of 13.1 per 100,000 people. From 2018 to 2019, the rate of acute hepatitis B decreased by 10%. From 2018 to 2019, the rate of chronic hepatitis B decreased by 8%. From 2016 to 2019, the total reported rates of chronic hepatitis B decreased.
In 2019, there were 11,441 hepatitis C cases reported for a rate of 30.4 per 100,000 people. From 2015 to 2018, the total reported cases of hepatitis C increased. From 2018 to 2019, the total reported cases decreased by 10%.
Number and rate of hepatitis B in Canada, rate of chronic hepatitis B per age group, number and rate of hepatitis C in Canada, and rate change of hepatitis C in Canada.
This report presents the findings of the evaluation of the Public Health Agency of Canada’s (PHAC) viral hepatitis and sexually transmitted infection (STI) activities.
The Canada Communicable Disease Report (CCDR) is a bilingual, peer-reviewed, open-access, online scientific journal published by the Public Health Agency of Canada (PHAC). It provides timely, authoritative and practical information on infectious diseases to clinicians, public health professionals, and policy-makers to inform policy, program development and practice.
In 2017, An estimated 10,900 new hepatitis C infections occurred.
Every hour, at least 1 person was infected with hepatitis C in Canada.
The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
Hepatitis C is a liver disease caused by the hepatitis C virus.
67% of Canadians reported never being tested for HCV. 44% of those living with HCV are unaware of their infection.
The 2018 survey asks Canadians questions about awareness, knowledge, attitudes, and behaviours related to Sexually Transmitted and Blood-Borne Infections (STBBI). To some extent, the survey builds on previous surveys commissioned by the Public Health Agency of Canada in 2003, 2006, and 2012, although most of the current survey has been redesigned to align with current program objectives. Evidence gathered through this survey is intended to enhance the capacity of all players to contribute to reduce the health impact of STBBI in Canada by 2030.